Showing results (1-10 of 391) with videos related to
Sort By:
Pageof 40
Advanced Drug Delivery Reviews|November 25, 2015
Integrating chemoradiation and molecularly targeted therapyDaniel R Wahl, Theodore S LawrenceClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2018
No Sugar Added: A New Strategy to Inhibit Glioblastoma Receptor Tyrosine KinasesDaniel R Wahl, Theodore S LawrenceFrontiers in Oncology|August 2, 2021
Survival Prediction Analysis in Glioblastoma With Diffusion Kurtosis ImagingYuan Li, Michelle M Kim, Daniel R Wahl, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2015
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular CarcinomaDaniel R Wahl, Matthew H Stenmark, Yebin Tao, et al.International Journal of Radiation Oncology, Biology, Physics|July 8, 2018
Combining Perfusion and High B-value Diffusion MRI to Inform Prognosis and Predict Failure Patterns in GlioblastomaDaniel R Wahl, Michelle M Kim, Madhava P Aryal, et al.Oncology (Williston Park, N.Y.)|January 16, 2004
Radiation sensitizers and targeted therapiesTheodore S LawrenceNeuro-Oncology|February 18, 2021
Response assessment during chemoradiation using a hypercellular/hyperperfused imaging phenotype predicts survival in patients with newly diagnosed glioblastomaMichelle M Kim, Madhava P Aryal, Yilun Sun, et al.Neuro-Oncology Practice|November 17, 2022
Efficacy and toxicity with radiation field designs and concurrent temozolomide for CNS lymphomaAnna M Laucis, Katherine Selwa, Yilun Sun, et al.Current Issues in Molecular Biology|July 29, 2025
A New Tool to Decrease Interobserver Variability in Biomarker Annotation in Solid Tumor Tissue for Spatial Transcriptomic AnalysisSravya Palavalasa, Emily Baker, Jack Freeman, et al.Molecular Cancer Therapeutics|December 3, 2020
Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination-Proficient Pancreatic CancerLeslie A Parsels, Carl G Engelke, Joshua Parsels, et al.Pageof 40